A Study of Gastric Delay in Migraine Patients (3207-003)

• Status: Completed
• Trial end date: 2010-02-01
• Target enrollment: 0
• Participant gender: All

Summary

A study to assess safety and PK of an investigational drug in migraine patients during and between migraine attacks.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.

Criteria

Inclusion Criteria:

• Non-smoking male or female between 18 to 45 years of age

• Patient typically has between 2 and 10 migraine attacks per month, rated as moderate or severe

Exclusion Criteria:

• Patient has any other medical conditions other than migraine